Skip to main content Skip to megamenu
Meet us next:   NIH Research Festival 2024  24 September  •  Safety Pharmacology Society 2024  22-24 September  •  Drug Discovery 2024 - ELRIG  2-3 October  •  Other upcoming events

CRISPR/Cas9 using SNIPER Technology - Managing Challenging Cases

 

About the speaker

Dr-Sugo-2Dr. Tsukasa Sugo is CEO and Founder of GenAhead Bio in Fujisawa, Japan. Dr. Sugo earned his BS and Ph.D. degrees from Tokyo University. Prior to founding GenAhead Bio, Dr. Sugo worked at Takeda Pharmaceutical Company, leading research teams in genome editing, nucleic acid research and G-protein coupled receptors. He held a visiting scientist position at Alnylam Pharmaceuticals in the Boston area.


More information